BofA Securities reiterates Underperform rating on Dow stock amid European closures

Published 07/07/2025, 16:32
BofA Securities reiterates Underperform rating on Dow stock amid European closures

Investing.com - BofA Securities has reiterated its Underperform rating and $27.00 price target on Dow Inc. (NYSE:DOW), currently trading at $27.76, following the company’s announcement of European facility closures. The chemical giant, which offers a notable 9.84% dividend yield, has seen its stock decline over 41% in the past year. According to InvestingPro analysis, the stock appears undervalued at current levels.

Dow announced it will close three European operations, including a smaller ethylene cracker in Böhlen, Germany, a small chlor-alkali complex in Schkopau, Germany, and a larger siloxanes operation in Barry, UK.

The closures come as chemical companies adjust their operations in response to significant capacity investments from China that are still being absorbed by the industry, according to BofA Securities.

The investment firm noted that European operations have become increasingly unfavorable for chemical companies due to higher energy costs and increased regulatory scrutiny.

No update was provided on Dow’s European polyurethanes business, which remains under review, with BofA Securities suggesting that buyer interest in that business "may be tepid."

In other recent news, Dow Inc. announced plans to shut down three upstream assets in Europe, citing structural challenges in the region. This decision is expected to impact approximately 800 roles and result in charges between $630 million and $790 million. The company anticipates an EBITDA uplift of $200 million by 2029 due to these closures. Additionally, Mizuho (NYSE:MFG) maintained its Neutral rating on Dow but lowered its price target to $31, citing ongoing challenges in the chemicals sector, particularly with polyethylene pricing. Mizuho also reduced its second-quarter EBITDA estimate for Dow to $797 million, reflecting a 16% decrease. Meanwhile, BMO Capital downgraded Dow from Market Perform to Underperform, reducing the price target to $22, due to weak market conditions affecting the company’s financial performance. In legal developments, a Canadian court ordered NOVA Chemicals to pay Dow approximately USD$1.2 billion in additional damages related to a jointly owned ethylene asset. This judgment follows a previous payment to Dow in 2019 and is subject to appeal.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.